About bioceres crop solutions corp - BIOX
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.
BIOX At a Glance
Bioceres Crop Solutions Corp.
Ocampo 210 bis
Rosario, Santa Fe S2000
| Phone | 54-34-1486-1100 | Revenue | 333.34M | |
| Industry | Chemicals: Agricultural | Net Income | -55,416,054.00 | |
| Sector | Process Industries | Employees | 751 | |
| Fiscal Year-end | 06 / 2026 | |||
| View SEC Filings |
BIOX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.848 |
| Price to Book Ratio | 1.061 |
| Price to Cash Flow Ratio | 9.13 |
| Enterprise Value to EBITDA | 38.987 |
| Enterprise Value to Sales | 1.691 |
| Total Debt to Enterprise Value | 0.507 |
BIOX Efficiency
| Revenue/Employee | 443,866.827 |
| Income Per Employee | -73,789.686 |
| Receivables Turnover | 1.875 |
| Total Asset Turnover | 0.413 |
BIOX Liquidity
| Current Ratio | 0.912 |
| Quick Ratio | 0.629 |
| Cash Ratio | 0.103 |
BIOX Profitability
| Gross Margin | 34.167 |
| Operating Margin | -2.318 |
| Pretax Margin | -16.933 |
| Net Margin | -16.624 |
| Return on Assets | -6.866 |
| Return on Equity | -19.76 |
| Return on Total Capital | -10.223 |
| Return on Invested Capital | -14.617 |
BIOX Capital Structure
| Total Debt to Total Equity | 111.608 |
| Total Debt to Total Capital | 52.743 |
| Total Debt to Total Assets | 37.438 |
| Long-Term Debt to Equity | 22.256 |
| Long-Term Debt to Total Capital | 10.518 |